Literature DB >> 20802346

Prognostic impact of node involvement pattern in pN1 non-small cell lung cancer patients.

Masayuki Nakao1, Junji Yoshida, Genichiro Ishii, Akikazu Kawase, Ryo Maeda, Keiju Aokage, Tomoyuki Hishida, Mitsuyo Nishimura, Kanji Nagai.   

Abstract

INTRODUCTION: We previously showed that squamous cell carcinoma (SCC) patients with directly involved N1 nodes resulted in outcomes significantly better than those with separately involved N1 nodes. The purpose of this study was to evaluate the prognostic effect of node involvement patterns in pN1 non-small cell lung cancer (NSCLC) patients, with special attention given to any differences between SCC and adenocarcinoma (AD).
METHODS: We reviewed 324 consecutive patients with completely resected pN1 NSCLC and classified them into two groups based on their node involvement patterns: directly or separately involved N1 groups. To compare survival rates, 1545 pN0 patients and 330 pN2 patients were also investigated.
RESULTS: Univariate and multivariate analyses showed that the node involvement pattern was significantly associated with pN1 NSCLC patient outcome. The directly involved N1 group had a much better 5-year overall survival rate of 60.1% compared with 45.0% for the separately involved N1 group. In SCC patients, the directly involved N1 group showed an overall survival similar to pN0 patients, whereas overall survival of the separately involved N1 group was identical to that of pN2 patients, and their survival rates were significantly different. In AD patients, however, the survival rates were marginally different between the directly and separately involved N1 groups, and they were intermediate between pN0 and pN2 patient survival rates.
CONCLUSIONS: Node involvement patterns had significant prognostic effect in pN1 NSCLC patients. This effect was different between SCC and AD cases. The subclassification of N1 based on node involvement pattern is of significance for SCC patients but not for AD patients.

Entities:  

Mesh:

Year:  2010        PMID: 20802346     DOI: 10.1097/JTO.0b013e3181ec7e70

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  4 in total

1.  Prognostic impact of extranodal extension in patients with pN1-N2 lung adenocarcinoma.

Authors:  Kotaro Nomura; Keiju Aokage; Tokiko Nakai; Shingo Sakashita; Tomohiro Miyoshi; Kenta Tane; Joji Samejima; Kenji Suzuki; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-02       Impact factor: 4.553

2.  Comparison of prognostic values of primary tumor and nodal 18F-fluorodeoxyglucose uptake in non-small cell lung cancer with N1 disease.

Authors:  Chae Hong Lim; Seung Hyup Hyun; Seung Hwan Moon; Young Seok Cho; Joon Young Choi; Kyung-Han Lee
Journal:  Eur Radiol       Date:  2019-03-21       Impact factor: 5.315

3.  Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer.

Authors:  Takayuki Fukui; Katsuhiko Kato; Toshiki Okasaka; Koji Kawaguchi; Koichi Fukumoto; Shota Nakamura; Shuhei Hakiri; Naoki Ozeki; Kohei Yokoi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-09-02

4.  Sphingomyelin(d35:1) as a novel predictor for lung adenocarcinoma recurrence after a radical surgery: a case-control study.

Authors:  Yusuke Takanashi; Kazuhito Funai; Shumpei Sato; Akikazu Kawase; Hong Tao; Yutaka Takahashi; Haruhiko Sugimura; Mitsutoshi Setou; Tomoaki Kahyo; Norihiko Shiiya
Journal:  BMC Cancer       Date:  2020-08-24       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.